Table 2.
Survived to 1 year | Diarrhoea-associated deaths | Diarrhoea-associated mortality rate per 1000 | Vaccine coverage, % of eligible infants | Vaccination impact*(95% CI); p value) | |
---|---|---|---|---|---|
Prevaccination cohort | 7690 | 44 | 5·6 | NA | .. |
Vaccine eligible cohort | 28 718 | 108 | 3·7 | 91% | 31% (1–52); 0·043 |
January–June, 2012 (preRV1) | 4232 | 28 | 6·6 | NA | .. |
January–June, 2013 | 4339 | 16 | 3·7 | 89% | 39% (10–59); 0·013 |
January–June, 2014 | 4180 | 9 | 2·1 | 94% | 76% (58–86); <0·001 |
January–June, 2015 | 3830 | 10 | 2·6 | 95% | 68% (47–81); <0·001 |
NA=not applicable. RV=rotavirus.
1 minus relative rate reduction in mortality following vaccine introduction compared with pre-introduction rate, using adjusted Poisson regression (adjusted for marital status, mother's education, quality of house, toilet and water source, and household assets).